Neogenomics Inc
NEO8.620USD
+0.510+6.29%
收盘 09/18, 16:00（美东）报价延迟15分钟
1.11B总市值
亏损市盈率 TTM
关于 Neogenomics Inc 公司
NeoGenomics, Inc. 提供一系列肿瘤诊断测试和咨询服务，包括技术实验室服务。该公司由专门从事病理学和肿瘤学的执业医师提供对实验室测试结果的专业解释。其部门包括临床服务和高级诊断。临床服务部门包括临床癌症检测；解释和咨询服务；分子和 NGS 检测，以及全面的技术和专业服务。其临床服务客户包括社区病理学和肿瘤学诊所、医院病理学实验室、参考实验室和学术中心。高级诊断部门包括临床试验和研究、验证实验室服务和信息学。其高级诊断客户包括制药公司，该公司为其提供测试和其他服务以支持其研究和临床试验。
公司简介
公司代码NEO
公司名称Neogenomics Inc
上市日期Dec 10, 2012
CEOMr. Antony P. Zook
员工数量2200
证券类型Ordinary Share
年结日Dec 10
公司地址9490 Neogenomics Way
城市FORT MYERS
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编33912
电话12397680600
网址https://neogenomics.com/
公司代码NEO
上市日期Dec 10, 2012
CEOMr. Antony P. Zook
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. Antony P. Zook
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
暂无数据
业务
地区
业务USD
名称
营收
占比
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
其他
60.32%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
其他
60.32%
股东类型
持股股东
占比
Investment Advisor
50.14%
Investment Advisor/Hedge Fund
31.89%
Hedge Fund
14.04%
Research Firm
2.36%
Individual Investor
1.29%
Pension Fund
1.17%
Bank and Trust
0.61%
Sovereign Wealth Fund
0.09%
Family Office
0.05%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
18.29M
14.21%
-356.84K
-1.91%
Mar 31, 2025
The Vanguard Group, Inc.
14.23M
11.06%
+17.23K
+0.12%
Mar 31, 2025
Greenhouse Funds LLLP
4.71M
3.66%
+6.43K
+0.14%
Mar 31, 2025
First Light Asset Management, LLC
6.04M
4.7%
+2.88M
+90.77%
Mar 31, 2025
State Street Global Advisors (US)
5.09M
3.95%
-109.12K
-2.10%
Mar 31, 2025
Macquarie Investment Management
4.68M
3.63%
+864.39K
+22.67%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.85M
2.99%
+408.27K
+11.88%
Mar 31, 2025
Schroder Investment Management North America Inc.
4.31M
3.35%
+509.99K
+13.42%
Mar 31, 2025
American Century Investment Management, Inc.
3.32M
2.58%
+426.34K
+14.74%
Mar 31, 2025
Millennium Management LLC
6.72M
5.22%
+5.29M
+371.20%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
